CF Foundation | Nontuberculous Mycobacteria (NTM)

Published on september 18, 2018 by

Dave Nichols, M.D., medical director of the Therapeutics Development Network Coordinating Center at Seattle Children’s Hospital, updates us on new developments in research on nontuberculous mycobacteria (NTM), which is becoming an increasing problem in people with cystic fibrosis. Dr. Nichols talks about how clinicians determine whether to treat people with CF who culture NTM and what researchers are doing to better understand this bacteria to improve treatment.


Add your comment

Your email address will not be published.